samedan logo
home > pmps > autumn 2021 > how the war on covid-19 is driving innovation in temperature-controlled packaging
Pharmaceutical Manufacturing and Packing Sourcer

How the War on COVID-19 Is Driving Innovation In Temperature-Controlled Packaging

It has been a tough 18 months. At times, throughout 2020, it has felt like we have been facing a battle with little end in sight. Although this may seem like an overly dramatic statement, the challenges brought by COVID-19 have invoked all kinds of wartime comparisons – we talk about health professionals on the ‘front line’ in the UK lockdown, rekindling memories of the ‘blitz spirit’, news conferences speak about defeating the infection as if it is a physical opponent, with some going as far as to label the virus as an ‘invisible enemy’. And, of course, the grim reality of the tragic deaths caused by the pandemic regularly reminds us that lives are at stake.

Yet in a switch of perspective, we can also seek a more positive parallel between the last few months and times of war: the inevitable and necessary acceleration in innovation – and innovative thinking – that is driven by the need to overcome a crisis.

In this article, I want to outline how I believe the vital work being done to defeat COVID-19 is sparking innovative thinking and driving change, by looking at the pharmaceutical packaging sector both in terms of method of delivery and sustainability. It is also proving what can be done to make a change through collaboration, focus, and the will of humanity.

Of course, I am not seeking to deny or downplay the clear challenges and tragic impact on so many that COVID-19 has brought with it. However, I want to focus on what could be the postvirus positives, those takeaways that I, personally, feel are so important to keep focusing on, in times like this. We all need a potential silver lining when things feel so dark.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

Josie Morris BA (Hons) MA is Managing Director of The Wool Packaging Company Limited – Woolcool. A passionate advocate for diversity and the development of strong cultures within innovative businesses, Josie is also closely involved with organisations such as the Bio-Based Industries Association, which lobby the UK Government on the environmental problems of global packaging waste, and support pioneering companies that offer genuinely sustainable alternatives to plastic materials.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera wins Pharmapack Award in Connected Devices and Wearables category with its body injector platform Symbioze

Symbioze, the smart, high volume and sustainable on-body injector platform developed by Nemera, wins the ‘Connected Devices and Wearables’ Award at Pharmapack 2021 On October 12th, during the Pharmapack Awards Ceremony, a team of industry experts awarded Symbioze, Nemera’s large-volume on-body injector, with the Pharmapack Award in the “Connected Devices and Wearables” category.
More info >>

White Papers

Medpace Reference Laboratories establishes state of the art Flow Cytometry techniques for flexible approaches to clinical trials across multiple therapeutic areas.


Cytometry is the process of measuring the properties of individual cells. These properties may include gene or protein expression, chemical properties, deoxyribonucleic acid (DNA) content, and various cellular functions. The earliest methods of cytometry relied upon light microscopy for the classification and observation of cells and cellular components. Microscopy permitted direct visual observation of cells for the first time, leading to the classification of cells by morphology and insight into cellular functions. However, the time required for microscopic analysis constrains the number of samples or number of cells in each sample that can be examined. Therefore, the utility of microscopy for analysis of rare cells or in situations where sample throughput is a priority is limited. Flow cytometry was developed largely to improve upon these limitations.
More info >>




©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement